Bio Essence (BIOE) Net Cash Flow (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Net Cash Flow of $36177.0 in Q1 2026, up 225.87% quarter-over-quarter from -$28741.0 in Q4 2025, and up 2738.73% on a YoY basis from $1274.4 in Q1 2025.
Bio Essence (BIOE) Net Cash Flow (2020 - 2026) Analysis & Trends
Bio Essence's Net Cash Flow history runs 7 years deep, the most recent figure standing at $36177.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 2738.73% year-over-year to $36177.0; the TTM figure through Mar 2026 stood at $36177.0 (up 43.26% YoY), while the FY2025 annual figure was -$1371.0, down 105.17% from the prior year.
- Net Cash Flow was $36177.0 for Q1 2026 at Bio Essence, up from -$28741.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $412926.0 in Q2 2023 to a low of -$361617.0 in Q3 2023.
- Historically, Net Cash Flow has averaged $20857.2 across 5 years, with a median of $943.5 in 2022.
- Biggest YoY gain for Net Cash Flow was 28655.29% in 2023; the steepest drop was 80281.15% in 2023.
- A 5-year view of Net Cash Flow shows it stood at $72776.0 in 2022, then jumped by 109.55% to $152504.0 in 2023, then plunged by 108.19% to -$12495.0 in 2024, then plunged by 130.02% to -$28741.0 in 2025, then surged by 225.87% to $36177.0 in 2026.
- The last three Net Cash Flow figures came in at $36177.0 (Q1 2026), -$28741.0 (Q4 2025), and $28741.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | 36,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,177.00 |
| Mar 31, 2026 | 36,177.00 |
| Dec 31, 2025 | -28,741.00 |
| Dec 31, 2025 | -28,741.00 |
| Sep 30, 2025 | 28,741.00 |
| Sep 30, 2025 | 28,741.00 |
| Mar 31, 2025 | -1,371.00 |
| Mar 31, 2025 | -1,371.00 |
| Dec 31, 2024 | -12,495.00 |
| Dec 31, 2024 | -12,495.00 |
| Sep 30, 2024 | 20,329.00 |
| Sep 30, 2024 | 20,329.00 |
| Jun 30, 2024 | 18,789.00 |
| Jun 30, 2024 | 18,789.00 |
| Mar 31, 2024 | 23.00 |
| Mar 31, 2024 | 23.00 |
| Dec 31, 2023 | 152,504.00 |
| Dec 31, 2023 | 152,504.00 |
| Sep 30, 2023 | -361,617.00 |
| Sep 30, 2023 | -361,617.00 |